Dimethylformamide → tert-Butyl 4-[(5-bromopyrimidin-2-yl)oxy]piperidine-1-carboxylate
Reaction equation
[C:1]([O:5][C:6]([N:8]1[CH2:13][CH2:12][CH:11]([OH:14])[CH2:10][CH2:9]1)=[O:7])([CH3:4])([CH3:3])[CH3:2].C(=O)([O-])[O-].[Cs+].[Cs+].CN(C=O)C.Cl[C:27]1[N:32]=[CH:31][C:30]([Br:33])=[CH:29][N:28]=1>O>[C:1]([O:5][C:6]([N:8]1[CH2:13][CH2:12][CH:11]([O:14][C:27]2[N:32]=[CH:31][C:30]([Br:33])=[CH:29][N:28]=2)[CH2:10][CH2:9]1)=[O:7])([CH3:4])([CH3:2])[CH3:3]Participants
6
Reactant 4
Product 1
Reagents, catalysts & solvents 1
Procedure
1-t-butoxycarbonyl-4-hydroxypiperidine (408 mg, 2.03 mmol) and cesium carbonate (764 mg, 2.34 mmol) were added to a DMF solution (10 ml) of 2-chloro-5-bromopyrimidine (300 mg, 1.56 mmol), and stirred at room temperature for 14 hours. Water was added to the reaction mixture, and extracted with ethyl acetate. The organic layer was washed with saturated saline, dried with anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was purified through silica gel column chromatography (C-300, hexane:ethyl acetate=10:1) to obtain the entitled compound (268 mg, 48%).
Workup
- extractionextracted with ethyl acetate
- washThe organic layer was washed with saturated saline
- dry with materialdried with anhydrous sodium sulfate
- concentrationconcentrated under reduced pressure
- customThe residue was purified through silica gel column chromatography (C-300, hexane:ethyl acetate=10:1)
Sources & evidence
- ORD record
- ord-a38f7e5444de4c97a75355d09989ea76
- Source dataset
- uspto-grants-2011_10
- Patent number
- US08044070B2
Reaction notes
Loading…